(1)
Babak, O. Y.; Lapshyna, K. A. The Fibroblasts Growth Factor 21 Study in Patients With Non-Alcoholic Fatty Liver Disease and Hypertension Comorbidities. Zaporozhye medical journal 2020, 22.